Lineage Cell Therapeutics Inc (LCTX) valuation · rev $14.6M
Lineage Cell Therapeutics Inc (LCTX) rev $14.6M.
| Metric | Value |
|---|---|
| Market cap | $213.6M |
| Revenue | $14.6M |
| P/S | 14.7 |
LCTX valuation FAQ
What is LCTX's market cap?
Lineage Cell Therapeutics Inc (LCTX) market cap is $213.6M on the latest cached fundamentals snapshot.
What is LCTX's latest revenue?
Latest cached Lineage Cell Therapeutics Inc (LCTX) revenue was $14.6M. Statements: https://lician.com/financials/lctx
What is LCTX's price-to-sales ratio?
Lineage Cell Therapeutics Inc (LCTX) price-to-sales (P/S) is 14.7, cached market cap $213.6M divided by revenue $14.6M.
How many LCTX valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Lineage Cell Therapeutics Inc (LCTX): Market cap, Revenue, and P/S.
Where is LCTX valuation listed?
Cached valuation multiples for Lineage Cell Therapeutics Inc (LCTX) are listed at https://lician.com/valuation/lctx.
Not investment advice. Cached rows, not a live tape.